icon-folder.gif   Conference Reports for NATAP  
 
  AASLD
61th Annual Meeting of the American Association for the Study of Liver Diseases
Boston, MA, Hynes Convention Center
October 30-November 3, 2010
Back grey_arrow_rt.gif
 
 
 
No Impact of Insulin Resistance on Antiviral Efficacy of Telaprevir-based Regimen in HCV Genotype 1 Treatment-na´ve Patients: Subanalysis of C208 Study
 
 
  Reported by Jules Levin
AASLD Nov 2 2010 Boston
 
L Serfaty,1 X Forns,2 T Goeser,3 P Ferenci,4 F Nevens,5 G Carosi,6 JP Drenth,7 I Lonjon-Domanec,8 R DeMasi,9 G Picchio,9 M Beumont,10 P Marcellin11 1Liver Unit, H˘pital St Antoine, UPMC, Paris, France; 2Liver Unit, University of Barcelona, Barcelona, Spain; 3Klinikum der Universitat zu Koln, Cologne, Germany; 4Department of Internal Medicine 3, Medical University of Vienna, Vienna, Austria; 5Department of Hepatology, University Hospital Gasthuisberg, Leuven, Belgium; 6Clinic of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy; 7Radboud University Nijmegen Medical Center, Nijmegen, Netherlands; 8Janssen, Paris, France; 9Tibotec Inc., Titusville, NJ, USA; 10Tibotec BVBA, Beerse, Belgium; 11Hopital Beaujon, Clichy, France